Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results.
[en] Side effects of steroid use have led to efforts to minimize their use in transplantation. Two corticosteroid-free regimens were compared with a triple immunosuppressive therapy. Data from the original intent-to-treat (ITT) population (153 tacrolimus/basiliximab [Tac/Bas], 151 tacrolimus/MMF [Tac/MMF], and 147 tacrolimus/MMF/steroids [control]) were analyzed in a 12-month follow-up. Percentage of graft survival were 92.8%, 95.4%, and 95.9% (KM estimates 89.9%, 95.3%, 95.9%), percentage of surviving patients were 98.7%, 98.0%, and 100% (KM estimates 95.9%, 92.8%, and 100%). During months 7-12, graft loss occurred in 3 Tac/Bas, 2 Tac/MMF, and zero control patients, patient deaths in 1 Tac/Bas, 2 Tac/MMF, and zero control, and biopsy-proven acute rejection episodes in 4 Tac/Bas, 3 Tac/MMF, and zero control. Mean serum creatinine at month 12 was 141.9 +/- 69.6 muM, 144.0 +/- 82.1 muM, and 134.5 +/- 71.2 muM (ns). New-onset insulin use in previously non-diabetic patients at month 12 was 1/138, 6/127, and 4/126. Patient and graft survival as well as renal function at 12 months were not different between patient groups, despite considerably higher rates of acute rejection occurring within the first six months after transplantation in both steroid-free patient groups. Tac/Bas therapy might offer benefits in terms of a trend for a more favorable cardiovascular risk profile.
Disciplines :
Surgery
Author, co-author :
Kramer, B. K.
Klinger, M.
Wlodarczyk, Z.
Ostrowski, M.
Midvedt, K.
Stefoni, S.
Citterio, F.
Pietruck, F.
Squifflet, Jean-Paul ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Segoloni, G.
Kruger, B.
Sperschneider, H.
Banas, B.
Backman, L.
Weber, Mireille ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Département clinique des animaux de compagnie et des équidés
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Fellstrom, B., Risk factors for and management of post-transplantation cardiovascular disease (2001) BioDrugs, 15, p. 261
Ansell, B.M., Overview of the side effects of corticosteroid therapy (1991) Clin Exp Rheumatol, 9 (SUPPL. 6), p. 19
Hricik, D.E., O'Toole, M.A., Schulak, J.A., Herson, J., Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis (1993) J Am Soc Nephrol, 4, p. 1300
Kasiske, B.L., Chakkera, H.A., Louis, T.A., Ma, J.Z., A meta-analysis of immunosuppression withdrawal trials in renal transplantation (2000) J Am Soc Nephrol, 11, p. 1910
Pascual, J., Quereda, C., Zamora, J., Hernandez, D., Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials (2004) Transplantation, 78, p. 1548
Opelz, G., Döhler, B., Laux, G., Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients (2005) Am J Tansplant, 5, p. 720
Mayer, A.D., Dmitrewski, J., Sqifflet, J.P., Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection (1997) Transplantation, 64, p. 436
Vincenti, F., Jensik, S.C., Filo, R.S., Miller, J., Pirsch, J., A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years (2002) Transplantation, 73, p. 775
Krämer, B.K., Montagnino, G., Del Castillo, D., Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in renal transplantation: 2-year follow-up results (2005) Nephrol Dial Transplant, 20, p. 968
Vanrenterghem, Y., van Hooff, J.P., Squifflet, J.-.P., Minimization of immunosuppressive therapy after renal transplantation: results of a randomized, controlled trial (2005) Am J Transplant, 5, p. 87
Pascual, J., van Hooff, J.P., Salmela, K., Lang, P., Rigotti, P., Budde, K., Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant (2006) Transplantation, 82, p. 55
Nashan, B., Moore, R., Amlot, P., Schmidt, A.G., Abeywickrama, K., Soulillou, J.P., Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group (1997) Lancet, 350, p. 1193
Rostaing, L., Cantarovich, D., Mourad, G., Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation (2005) Transplantation, 79, p. 807
Vitko, S., Klinger, M., Salmela, K., Two corticosteroid-free regimens - tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil - in comparison with a standard triple regimen in renal transplantation: results of the ATLAS study (2005) Transplantation, 80, p. 1734
Solez, K., Axelsen, R.A., Benediktsson, H., International standardisation of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology (1993) Kidney Int, 44, p. 411
Solez, K., Cavallo, T., Croker, B., Report on the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology (1996) Transplant Proc, 28, p. 441
Grewal, H.P., Thistlethwaite, J.R., Loss, G.E., Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression (1998) Transplant Proc, 30, p. 1378
Matas, A.J., Humar, A., Gillingham, K.J., Five preventable causes of kidney graft loss in the 1990s: a single-center analysis (2002) Kidney Int, 62, p. 704
Jindal, R.M., Baines, L.S., Noncompliance after solid organ transplantation (2001) Transplantation, 72, p. 1583
Chisholm, M.A., Issues of adherence to immunosuppressant therapy after solid-organ transplantation (2002) Drugs, 62, p. 567
Krämer, B.K., Krüger, B., Mack, M., Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens (2005) Transplant Proc, 37, p. 1789
Wlodarczyk, Z., Walaszewski, J., Perner, F., Steroid withdrawal at three months after kidney transplantation: a comparison of two tacrolimus- based regimens (2005) Transpl Int, 18, p. 157
Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up (2001) Transplantation, 71, p. 1091
Krämer, B.K., Zülke, C., Kammerl, M.C., Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation (2003) Am J Transplant, 3, p. 982
Woodle, E.S., First, M.R., Pirsch, J., A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy (2008) Ann Surg, 248, p. 564
Matas, A.J., Kandaswamy, R., Gillingham, K.J., Prednisone-free maintenance immunosuppression - a 5-year experience (2005) Am J Transplant, 5, p. 2473
Kaufman, D.B., Leventhal, J.R., Axelrod, D., Gallon, L.G., Parkaer, M.A., Stuart, F.P., Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction - long-term results (2005) Am J Transplant, 5, p. 2539
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.